Skip to main content

OGT Licenses Microarray IP to Invitrogen

NEW YORK (GenomeWeb News) - Oxford Gene Technology has licensed its oligonucleotide microarray patents to Invitrogen, OGT said today.
 
With the license, Invitrogen can offer DNA related microarray services to customers worldwide from its US operations.
 
The license will remain valid for the patents’ lifetime.
 
Financial details were not disclosed.
 
OGT licensed its patents to four Japanese companies in August: Yamatake, NGK Insulators, Bio Matrix Research, and Filgen.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.